EUCTR2004-003701-24-IT进行中（未招募）1 期
A RANDOMISED, OPEN-LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF BEXAROTENE (TARGRETIN) CAPSULES COMBINED WITH PUVA, COMPARED TO PUVA TREATMENT ALONE IN PATIENTS WITH MYCOSIS FUNGOIDES.
E.O.R.T.C. - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER0 个研究点目标入组 0 人开始时间: 2005年8月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A clinical study to test the safety, tolerability and immune response of a vaccine against pneumococcal bacteria, presented in a multidose vial given with other vaccines to healthy infants.MedDRA version: 17.1Level: PTClassification code 10061353Term: Pneumococcal infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-000482-21-Outside-EU/EEAPfizer Inc500
进行中（未招募）
1 期
A trial to evaluate the safety and immune response of a pneumococcal conjugate vaccine in adults ?65 years old with previous pneumococcal vaccinatioPneumococcal InfectionsMedDRA version: 20.0Level: PTClassification code 10069578Term: Pneumococcal immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2018-004278-91-SEPfizer Inc., 235 East 42nd Street, New York, NY 10017875
已完成
3 期
A S ingle Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)JPRN-jRCT2071210141Kuriyama Kenji150
进行中（未招募）
不适用
Trial of Aeroquin versus Tobramycin Inhalation Solution(TIS) in Stable Cystic Fibrosis PatientsPseudomonas aeruginosa infection in patients suffering from stable Cystic FibrosisMedDRA version: 14.1Level: PTClassification code 10011763Term: Cystic fibrosis lungSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 14.1Level: LLTClassification code 10021860Term: Infection pseudomonas aeruginosaSystem Organ Class: 10021881 - Infections and infestationsEUCTR2010-019634-26-IEMpex Pharmaceuticals, Inc.330
进行中（未招募）
1 期
Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) PatientsPseudomonas aeruginosa infection in patients suffering from stable Cystic FibrosisMedDRA version: 14.0 Level: PT Classification code 10011763 Term: Cystic fibrosis lung System Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 14.0 Level: LLT Classification code 10021860 Term: Infection pseudomonas aeruginosa System Organ Class: 10021881 - Infections and infestationsEUCTR2010-019634-26-GBMpex Pharmaceuticals, Inc.330